CytoMed director Choo Chee Kong reports GDTC holdings

CytoMed Therapeutics Ltd director and more-than-10% owner Choo Chee Kong filed an initial Form 3 reporting his ownership in the company.

Accepted by SEC EDGAR 05/15/2026 - 09:00 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CytoMed Therapeutics Ltd director and more-than-10% owner Choo Chee Kong filed an initial Form 3 reporting his ownership in the company. The filing shows beneficial ownership of 2,075,310 Ordinary Shares held through Glorious Finance Limited, 194,112 Ordinary Shares held through EP Capital Inc., and 318,324 Ordinary Shares held directly by Mr. Choo. He disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance to the extent he has no economic interest in those shares.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Choo Chee Kong

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Holding	Ordinary Shares, no par value per share	--	--	--
Holding	Ordinary Shares, no par value per share	--	--	--
Holding	Ordinary Shares, no par value per share	--	--	--

Holdings: Ordinary Shares, no par value per share — 2,075,310 shares (Indirect, Via 55% ownership of Glorious Finance Limited); Ordinary Shares, no par value per share — 194,112 shares (Indirect, Via 100% ownership of EP Capital Inc.); Ordinary Shares, no par value per share — 318,324 shares (Direct)

Footnotes (3)

1. F1. 3,773,291 Ordinary Shares is presently held by Glorious Finance Limited ("Glorious Finance"). CHOO Chee Kong ("Mr. Choo") owns 55.0% of shares in Glorious Finance and has beneficial ownership of 2,075,310 Ordinary Shares. Mr. Choo disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance to the extent that he does not have an economic interest therein;
2. F2. 194,112 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. Choo is deemed to beneficially own the 194,112 Ordinary Shares held by EP Capital, and
3. F3. 318,324 Ordinary Shares held directly by Mr. Choo.

Key Figures

Shares held by Glorious Finance Limited: 3,773,291 Ordinary Shares Beneficially owned via Glorious Finance: 2,075,310 Ordinary Shares Shares disclaimed at Glorious Finance: 1,697,981 Ordinary Shares +2 more

5 metrics

Shares held by Glorious Finance Limited 3,773,291 Ordinary Shares Held by Glorious Finance Limited; Mr. Choo owns 55.0% of this entity

Beneficially owned via Glorious Finance 2,075,310 Ordinary Shares Portion of Glorious Finance holdings attributed as beneficially owned by Mr. Choo

Shares disclaimed at Glorious Finance 1,697,981 Ordinary Shares Ordinary Shares for which Mr. Choo disclaims beneficial ownership

Indirect holdings via EP Capital Inc. 194,112 Ordinary Shares Ordinary Shares held by EP Capital Inc., deemed beneficially owned by Mr. Choo

Direct holdings 318,324 Ordinary Shares Ordinary Shares held directly by Mr. Choo

Key Terms

beneficial ownership, disclaims beneficial ownership, indirect ownership, ten percent owner, +1 more

5 terms

beneficial ownership financial

"has beneficial ownership of 2,075,310 Ordinary Shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

disclaims beneficial ownership financial

"Mr. Choo disclaims beneficial ownership of 1,697,981 Ordinary Shares"

indirect ownership financial

"Via 100% ownership of EP Capital Inc."

ten percent owner financial

"is_ten_percent_owner": 1"

Ordinary Shares, no par value per share financial

"security_title": "Ordinary Shares, no par value per share""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CytoMed Therapeutics (GDTC) director Choo Chee Kong report on this Form 3?

He reports his initial ownership in CytoMed Therapeutics. The filing lists beneficial holdings in Ordinary Shares held directly and through entities he controls, providing a baseline view of his equity stake and related indirect interests.

How many CytoMed Therapeutics (GDTC) shares are attributed to Glorious Finance Limited?

Glorious Finance Limited holds 3,773,291 Ordinary Shares. Mr. Choo owns 55.0% of Glorious Finance and is reported as beneficially owning 2,075,310 of those shares, while disclaiming beneficial ownership of 1,697,981 shares without an economic interest.

What indirect CytoMed Therapeutics (GDTC) holdings does EP Capital Inc. report for Mr. Choo?

EP Capital Inc. holds 194,112 Ordinary Shares of CytoMed Therapeutics. Mr. Choo is deemed to beneficially own these 194,112 shares through his ownership of EP Capital, adding to his indirect stake in the company alongside other reported positions.

How many CytoMed Therapeutics (GDTC) shares does Choo Chee Kong hold directly?

He directly holds 318,324 Ordinary Shares. This direct position is reported separately from his indirect holdings through Glorious Finance Limited and EP Capital Inc., giving a clearer breakdown of how his overall ownership is structured.

Does Choo Chee Kong disclaim any beneficial ownership in CytoMed Therapeutics (GDTC)?

Yes. He disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance Limited to the extent he has no economic interest in them. This clarification limits his reported beneficial stake to shares in which he has economic exposure.

Is this CytoMed Therapeutics (GDTC) Form 3 a record of trades or a baseline ownership filing?

It is a baseline ownership filing. The Form 3 lists Mr. Choo’s direct and indirect Ordinary Share holdings as of the reporting date, without reporting specific buy or sell transactions or option exercises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Choo Chee Kong

(Last) (First) (Middle)

C/O CYTOMED THERAPEUTICS LIMITED

1 COMMONWEALTH LANE #08-22

(Street)

SINGAPORE 149544

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
CytoMed Therapeutics Ltd [ GDTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, no par value per share	2,075,310(1)	I	Via 55% ownership of Glorious Finance Limited
Ordinary Shares, no par value per share	194,112(2)	I	Via 100% ownership of EP Capital Inc.
Ordinary Shares, no par value per share	318,324(3)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 3,773,291 Ordinary Shares is presently held by Glorious Finance Limited ("Glorious Finance"). CHOO Chee Kong ("Mr. Choo") owns 55.0% of shares in Glorious Finance and has beneficial ownership of 2,075,310 Ordinary Shares. Mr. Choo disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance to the extent that he does not have an economic interest therein;

2. 194,112 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. Choo is deemed to beneficially own the 194,112 Ordinary Shares held by EP Capital, and

3. 318,324 Ordinary Shares held directly by Mr. Choo.

	/s/ Chee Kong Choo	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)